Barclays Boosts UiPath (NYSE:PATH) Price Target to $14.00

UiPath (NYSE:PATH - Get Free Report) had its target price hoisted by research analysts at Barclays from $12.00 to $14.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has an "equal weight" rating on the stock. Barclays's price target points to a potential upside of 5.42% from the stock's previous close.

A number of other equities analysts have also recently commented on PATH. Bank of America reissued an "underperform" rating and issued a $10.00 price objective (down from $18.00) on shares of UiPath in a research note on Thursday, March 13th. Mizuho dropped their price target on shares of UiPath from $12.00 to $11.00 and set a "neutral" rating for the company in a research note on Tuesday, April 15th. Evercore ISI dropped their price target on shares of UiPath from $16.00 to $12.00 and set an "in-line" rating for the company in a research note on Thursday, March 13th. Needham & Company LLC reaffirmed a "hold" rating on shares of UiPath in a research note on Friday. Finally, Morgan Stanley dropped their price target on shares of UiPath from $16.00 to $12.00 and set an "equal weight" rating for the company in a research note on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $13.41.

UiPath Stock Performance

Shares of NYSE:PATH traded up $0.34 on Friday, reaching $13.28. The company's stock had a trading volume of 47,371,291 shares, compared to its average volume of 10,666,374. UiPath has a 52-week low of $9.38 and a 52-week high of $15.93. The company has a market cap of $7.32 billion, a P/E ratio of -83.00 and a beta of 1.01. The company has a 50-day simple moving average of $11.53 and a 200 day simple moving average of $12.69.

UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of $0.10 by $0.01. UiPath had a negative net margin of 6.49% and a negative return on equity of 4.14%. The business had revenue of $356.62 million during the quarter, compared to analysts' expectations of $332.17 million. During the same period last year, the company posted $0.13 EPS. The business's revenue was up 6.4% on a year-over-year basis. On average, equities research analysts forecast that UiPath will post -0.17 EPS for the current fiscal year.

Insider Buying and Selling at UiPath

In other news, CAO Hitesh Ramani sold 12,500 shares of the business's stock in a transaction dated Thursday, April 3rd. The shares were sold at an average price of $10.19, for a total value of $127,375.00. Following the completion of the sale, the chief accounting officer now owns 314,891 shares in the company, valued at approximately $3,208,739.29. The trade was a 3.82% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Ashim Gupta sold 98,795 shares of the business's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $12.01, for a total transaction of $1,186,527.95. Following the completion of the sale, the chief financial officer now owns 987,322 shares of the company's stock, valued at approximately $11,857,737.22. This represents a 9.10% decrease in their position. The disclosure for this sale can be found here. 23.19% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On UiPath

Several large investors have recently modified their holdings of PATH. Smartleaf Asset Management LLC raised its stake in shares of UiPath by 88.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,454 shares of the company's stock worth $31,000 after acquiring an additional 1,152 shares in the last quarter. Versant Capital Management Inc raised its stake in shares of UiPath by 198.6% during the 1st quarter. Versant Capital Management Inc now owns 2,962 shares of the company's stock worth $31,000 after acquiring an additional 1,970 shares in the last quarter. First Horizon Advisors Inc. raised its stake in shares of UiPath by 47.8% during the 4th quarter. First Horizon Advisors Inc. now owns 2,487 shares of the company's stock worth $32,000 after acquiring an additional 804 shares in the last quarter. CX Institutional bought a new position in shares of UiPath during the 1st quarter worth approximately $36,000. Finally, EverSource Wealth Advisors LLC raised its stake in shares of UiPath by 141.4% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,974 shares of the company's stock worth $38,000 after acquiring an additional 1,742 shares in the last quarter. Institutional investors own 62.50% of the company's stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.